• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞腺瘤出血的风险因素。

Risk factors for bleeding in hepatocellular adenoma.

机构信息

Department of Surgery, Amsterdam, The Netherlands.

出版信息

Br J Surg. 2014 Jun;101(7):847-55. doi: 10.1002/bjs.9493. Epub 2014 Apr 24.

DOI:10.1002/bjs.9493
PMID:24760723
Abstract

BACKGROUND

Hepatocellular adenoma (HCA) is a benign hepatic lesion that may be complicated by bleeding, although the risk of bleeding is ill-defined. The aim of this study was to assess risk factors for bleeding in patients diagnosed with HCA.

METHODS

Patients with HCA were included prospectively from January 2008 to July 2012. Patient characteristics were noted. Patients underwent dynamic magnetic resonance imaging (MRI) and/or computed tomography (CT) at presentation and during follow-up. Lesion characteristics on (follow-up) imaging were noted, and bleeding was graded as intratumoral (grade I), intrahepatic (grade II) or extrahepatic (grade III). The standard of reference for diagnosis was histopathology, or dynamic MRI and/or CT findings. Possible risk factors were included if mentioned in literature (lesion size, body mass index), or based on clinical experience (lesion location, visible vessels on imaging).

RESULTS

A total of 45 patients (median age 39 (range 22-60) years; 44 women) with 195 lesions (median size 24 (10-250) mm) were evaluated. Bleeding occurred in 29 patients (64 per cent) and in 42 lesions (21.5 per cent) with a median size of 62 (10-160) mm. Size was a risk factor for bleeding (P < 0.001), with an increased number of bleeding events in lesions of 35 mm or more. Exophytic lesions (protruding from liver) had more bleeding (16 of 24, 67 per cent) than intrahepatic (9 of 82, 11 per cent) or subcapsular (17 of 89, 19 per cent) lesions (P < 0.001). Lesions in segments II and III had more bleeds than those in the right liver (11 of 32 versus 31 of 163; P = 0.049), as did lesions in which peripheral or central arteries were visualized on imaging (10 of 13 versus 32 of 182 lesions with no visible vascularization; P < 0.001).

CONCLUSION

Risk factors for bleeding of HCA include diameter of 35 mm or more, visualization of lesional arteries, location in the left lateral liver, and exophytic growth.

摘要

背景

肝细胞腺瘤(HCA)是一种良性肝病变,尽管其出血风险尚未明确,但可能会并发出血。本研究旨在评估诊断为 HCA 的患者出血的危险因素。

方法

本前瞻性研究纳入了 2008 年 1 月至 2012 年 7 月期间的 HCA 患者。记录患者特征。所有患者在就诊时和随访期间均接受了动态磁共振成像(MRI)和/或计算机断层扫描(CT)检查。记录病变特征,并根据影像学表现将出血分级为肿瘤内(I 级)、肝内(II 级)或肝外(III 级)。诊断标准为组织病理学,或动态 MRI 和/或 CT 发现。如果文献中提到(病变大小、体重指数)或基于临床经验(病变位置、影像学上可见血管),则将可能的危险因素纳入其中。

结果

共评估了 45 例(中位年龄 39 岁[范围 22-60 岁];44 例女性)患者的 195 个病灶(中位大小 24 毫米[10-250 毫米])。29 例患者(64%)和 42 个病灶(21.5%)发生出血,中位病灶大小为 62 毫米[10-160 毫米]。病灶大小是出血的危险因素(P < 0.001),35 毫米或以上的病灶出血事件增加。外生性病变(突出于肝脏)比肝内(82 个中的 9 个,11%)或包膜下(89 个中的 17 个,19%)病变出血更多(24 个中的 16 个,67%)(P < 0.001)。II 段和 III 段的病灶比右肝的病灶出血更多(32 个中的 11 个与 163 个中的 31 个;P = 0.049),在影像学上显示病灶周围或中央动脉的病灶比无血管化的病灶出血更多(13 个中的 10 个与 182 个中的 32 个;P < 0.001)。

结论

HCA 出血的危险因素包括直径 35 毫米或以上、病灶动脉显影、病变位于左外侧肝脏、外生性生长。

相似文献

1
Risk factors for bleeding in hepatocellular adenoma.肝细胞腺瘤出血的风险因素。
Br J Surg. 2014 Jun;101(7):847-55. doi: 10.1002/bjs.9493. Epub 2014 Apr 24.
2
Management and outcome of hepatocellular adenoma with massive bleeding at presentation.呈现大量出血的肝细胞腺瘤的管理与结局
World J Gastroenterol. 2017 Jul 7;23(25):4579-4586. doi: 10.3748/wjg.v23.i25.4579.
3
Systematic review of haemorrhage and rupture of hepatocellular adenomas.系统综述肝细胞腺瘤的出血和破裂。
Br J Surg. 2012 Jul;99(7):911-6. doi: 10.1002/bjs.8762. Epub 2012 May 22.
4
Management of spontaneous haemorrhage and rupture of hepatocellular adenomas. A single centre experience.肝细胞腺瘤自发性出血和破裂的管理:单中心经验
Liver Int. 2006 May;26(4):433-8. doi: 10.1111/j.1478-3231.2006.01244.x.
5
Case-orientated approach to the management of hepatocellular adenoma.肝细胞腺瘤管理的病例导向方法。
Br J Surg. 2006 Dec;93(12):1495-502. doi: 10.1002/bjs.5511.
6
Retrospective study on timing of resection of hepatocellular adenoma.回顾性研究肝细胞腺瘤切除术的时机。
Br J Surg. 2017 Nov;104(12):1695-1703. doi: 10.1002/bjs.10594. Epub 2017 Aug 30.
7
Hepatic adenoma and focal nodular hyperplasia.肝腺瘤和局灶性结节性增生。
Surg Gynecol Obstet. 1991 Nov;173(5):426-31.
8
Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium.MRI 对肝细胞腺瘤与局灶性结节增生的诊断准确性:钆塞酸二钠的附加价值的前瞻性研究。
AJR Am J Roentgenol. 2012 Jul;199(1):26-34. doi: 10.2214/AJR.11.7750.
9
[Hepatocellular adenomas and pregnancy].[肝细胞腺瘤与妊娠]
Ned Tijdschr Geneeskd. 2012;156(38):A5102.
10
Risk factors for bleeding hepatocellular adenoma in a United States cohort.美国队列中出血性肝细胞腺瘤的危险因素。
Liver Int. 2022 Jan;42(1):224-232. doi: 10.1111/liv.15087. Epub 2021 Nov 12.

引用本文的文献

1
Clinical characteristics of 50 hepatocellular adenoma patients among 164 cases of glycogen storage disease type Ia.164例Ia型糖原贮积病患者中50例肝细胞腺瘤患者的临床特征
Eur J Pediatr. 2025 Jun 30;184(7):458. doi: 10.1007/s00431-025-06180-y.
2
Hepatocellular adenomas with severe intra-abdominal bleeding, related to an underlying coagulation disorder: a case report.伴有严重腹腔内出血的肝细胞腺瘤,与潜在的凝血障碍相关:一例报告。
J Med Case Rep. 2024 Aug 13;18(1):367. doi: 10.1186/s13256-024-04709-7.
3
Assessment of a multivariable model using MRI-radiomics, age and sex for the classification of hepatocellular adenoma subtypes.
使用MRI放射组学、年龄和性别对肝细胞腺瘤亚型进行分类的多变量模型评估。
Res Diagn Interv Imaging. 2024 Apr 5;10:100046. doi: 10.1016/j.redii.2024.100046. eCollection 2024 Jun.
4
Sonic hedgehog hepatocellular adenoma: magnetic resonance imaging features and correlation with histology.音猬因子相关性肝细胞腺瘤:磁共振成像特征及其与组织学的相关性
Eur Radiol. 2024 Jul;34(7):4649-4662. doi: 10.1007/s00330-023-10344-5. Epub 2023 Nov 28.
5
Bleeding hepatocellular adenoma: historical series and outcomes.出血性肝细胞腺瘤:历史系列和结果。
Rev Col Bras Cir. 2023 Jul 10;50:e20233549. doi: 10.1590/0100-6991e-20233549-en. eCollection 2023.
6
[Benign solid liver tumors].[肝脏良性实性肿瘤]
Chirurgie (Heidelb). 2023 Aug;94(8):744-754. doi: 10.1007/s00104-023-01809-w. Epub 2023 Feb 22.
7
Influence of progestin-only hormonal use on hepatocellular adenomas: A retrospective cohort study.仅孕激素激素使用对肝细胞腺瘤的影响:一项回顾性队列研究。
Contraception. 2023 Mar;119:109915. doi: 10.1016/j.contraception.2022.11.006. Epub 2022 Dec 5.
8
Benign liver tumours: understanding molecular physiology to adapt clinical management.良性肝肿瘤:了解分子生理学以适应临床管理。
Nat Rev Gastroenterol Hepatol. 2022 Nov;19(11):703-716. doi: 10.1038/s41575-022-00643-5. Epub 2022 Jul 14.
9
KETOgenic diet therapy in patients with HEPatocellular adenoma: study protocol of a matched interventional cohort study.生酮饮食疗法治疗肝细胞腺瘤患者:一项配对干预队列研究的研究方案。
BMJ Open. 2022 Feb 15;12(2):e053559. doi: 10.1136/bmjopen-2021-053559.
10
A Scoping Review of the Classification, Diagnosis, and Management of Hepatic Adenomas.肝腺瘤分类、诊断及管理的范围综述
J Gastrointest Surg. 2022 Apr;26(4):965-978. doi: 10.1007/s11605-022-05246-8. Epub 2022 Jan 26.